Literature DB >> 20156554

Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammation.

Lukas Kubala1, Kara R Schmelzer, Anna Klinke, Hana Kolarova, Stephan Baldus, Bruce D Hammock, Jason P Eiserich.   

Abstract

Acute inflammation is a common feature of many life-threatening pathologies, including septic shock. One hallmark of acute inflammation is the peroxidation of polyunsaturated fatty acids forming bioactive products that regulate inflammation. Myeloperoxidase (MPO) is an abundant phagocyte-derived hemoprotein released during phagocyte activation. Here, we investigated the role of MPO in modulating biologically active arachidonic acid (AA) and linoleic acid (LA) metabolites during acute inflammation. Wild-type and MPO-knockout (KO) mice were exposed to intraperitoneally injected endotoxin for 24 h, and plasma LA and AA oxidation products were comprehensively analyzed using a liquid chromatography-mass spectrometry method. Compared to wild-type mice, MPO-KO mice had significantly lower plasma levels of LA epoxides and corresponding LA- and AA-derived fatty acid diols. AA and LA hydroxy intermediates (hydroxyeicosatetraenoic and hydroxyoctadecadienoic acids) were also significantly lower in MPO-KO mice. Conversely, MPO-deficient mice had significantly higher plasma levels of cysteinyl-leukotrienes with well-known proinflammatory properties. In vitro experiments revealed significantly lower amounts of AA and LA epoxides, LA- and AA-derived fatty acid diols, and AA and LA hydroxy intermediates in stimulated polymorphonuclear neutrophils isolated from MPO-KO mice. Our results demonstrate that MPO modulates the balance of pro- and anti-inflammatory lipid mediators during acute inflammation and, in this way, may control acute inflammatory diseases. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156554      PMCID: PMC2856720          DOI: 10.1016/j.freeradbiomed.2010.02.010

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  59 in total

Review 1.  Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.

Authors:  Baohai Shao; Michael N Oda; John F Oram; Jay W Heinecke
Journal:  Curr Opin Cardiol       Date:  2006-07       Impact factor: 2.161

Review 2.  Eicosanoids.

Authors:  James A Cook
Journal:  Crit Care Med       Date:  2005-12       Impact factor: 7.598

3.  Copper- and magnesium protoporphyrin complexes inhibit oxidative modification of LDL induced by hemin, transition metal ions and tyrosyl radicals.

Authors:  Stylianos Kapiotis; Marcela Hermann; Markus Exner; Hilde Laggner; Bernhard M K Gmeiner
Journal:  Free Radic Res       Date:  2005-11

4.  Soluble epoxide hydrolase is a therapeutic target for acute inflammation.

Authors:  Kara R Schmelzer; Lukas Kubala; John W Newman; In-Hae Kim; Jason P Eiserich; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

Review 5.  Myeloperoxidase: friend and foe.

Authors:  Seymour J Klebanoff
Journal:  J Leukoc Biol       Date:  2005-02-02       Impact factor: 4.962

6.  Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors.

Authors:  Kara R Schmelzer; Bora Inceoglu; Lukas Kubala; In-Hae Kim; Steven L Jinks; Jason P Eiserich; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-01       Impact factor: 11.205

Review 7.  Inflammation and immune regulation by 12/15-lipoxygenases.

Authors:  Hartmut Kühn; Valerie B O'Donnell
Journal:  Prog Lipid Res       Date:  2006-03-31       Impact factor: 16.195

8.  Inducible nitric oxide synthase expression is inhibited by myeloperoxidase.

Authors:  Alan P Kumar; Colm Ryan; Victoria Cordy; Wanda F Reynolds
Journal:  Nitric Oxide       Date:  2005-08       Impact factor: 4.427

9.  Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36.

Authors:  Eugene A Podrez; Eugenia Poliakov; Zhongzhou Shen; Renliang Zhang; Yijun Deng; Mingjiang Sun; Paula J Finton; Lian Shan; Bogdan Gugiu; Paul L Fox; Henry F Hoff; Robert G Salomon; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-07-08       Impact factor: 5.157

Review 10.  Myeloperoxidase and its contributory role in inflammatory vascular disease.

Authors:  Denise Lau; Stephan Baldus
Journal:  Pharmacol Ther       Date:  2006-02-13       Impact factor: 12.310

View more
  19 in total

1.  Multi-pathway integrated adjustment mechanism of licorice flavonoids presenting anti-inflammatory activity.

Authors:  Xiaomeng Yu; Yongrui Bao; Xiansheng Meng; Shuai Wang; Tianjiao Li; Xin Chang; Weifeng Xu; Guanlin Yang; Tao Bo
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

2.  2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion.

Authors:  Peter Bui; Parrisa Solaimani; Xiaomeng Wu; Oliver Hankinson
Journal:  Toxicol Appl Pharmacol       Date:  2011-12-20       Impact factor: 4.219

3.  Identification and profiling of targeted oxidized linoleic acid metabolites in rat plasma by quadrupole time-of-flight mass spectrometry.

Authors:  Zhi-Xin Yuan; Stanley I Rapoport; Steven J Soldin; Alan T Remaley; Ameer Y Taha; Matthew Kellom; Jianghong Gu; Maureen Sampson; Christopher E Ramsden
Journal:  Biomed Chromatogr       Date:  2012-10-05       Impact factor: 1.902

4.  Characterization of changes in plasma and tissue oxylipin levels in LPS and CLP induced murine sepsis.

Authors:  Ina Willenberg; Katharina Rund; Song Rong; Nelli Shushakova; Faikah Gueler; Nils Helge Schebb
Journal:  Inflamm Res       Date:  2015-12-08       Impact factor: 4.575

5.  Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism.

Authors:  Katherine N Theken; Yangmei Deng; M Alison Kannon; Tricia M Miller; Samuel M Poloyac; Craig R Lee
Journal:  Drug Metab Dispos       Date:  2010-10-14       Impact factor: 3.922

6.  Exogenous rhTRX reduces lipid accumulation under LPS-induced inflammation.

Authors:  Gi-Yeon Han; Eun-Kyung Lee; Hey-won Park; Hyun-Jung Kim; Chan-Wha Kim
Journal:  Exp Mol Med       Date:  2014-01-10       Impact factor: 8.718

Review 7.  Role of the Vanins-Myeloperoxidase Axis in Colorectal Carcinogenesis.

Authors:  Francesco Mariani; Luca Roncucci
Journal:  Int J Mol Sci       Date:  2017-04-27       Impact factor: 5.923

8.  Neutrophil myeloperoxidase diminishes the toxic effects and mortality induced by lipopolysaccharide.

Authors:  Laurent L Reber; Caitlin M Gillis; Philipp Starkl; Friederike Jönsson; Riccardo Sibilano; Thomas Marichal; Nicolas Gaudenzio; Marion Bérard; Stephan Rogalla; Christopher H Contag; Pierre Bruhns; Stephen J Galli
Journal:  J Exp Med       Date:  2017-04-06       Impact factor: 14.307

9.  A real - life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough.

Authors:  Roxana K Mincheva; Tanya Z Kralimarkova; Miroslava Rasheva; Zlatko Dimitrov; Denislava Nedeva; Maria Staevska; Vera Papochieva; Penka Perenovska; Karina Bacheva; Vasil D Dimitrov; Todor A Popov
Journal:  Cough       Date:  2014-03-20

10.  Lung Neutrophilia in Myeloperoxidase Deficient Mice during the Course of Acute Pulmonary Inflammation.

Authors:  Silvie Kremserova; Tomas Perecko; Karel Soucek; Anna Klinke; Stephan Baldus; Jason P Eiserich; Lukas Kubala
Journal:  Oxid Med Cell Longev       Date:  2016-02-21       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.